ST. LOUIS--(BUSINESS WIRE)--Tripos™, a leading provider of drug discovery informatics products and services, today announced the release of Muse™, a new molecular design program that enables discovery scientists in various fields to accelerate the identification and optimization of lead candidates. Using Muse, CADD scientists and medicinal chemists can invent novel structures, scaffolds, or side-chains that meet specific design objectives.
